Navigation Links
HPV Vaccine Acceptability Study Announces Results
Date:6/15/2009

FORT WORTH, Texas, June 15 /PRNewswire-USNewswire/ -- Female caregivers of African American girls are reluctant to have their children vaccinated against the human papillomavirus (HPV), according to a new study by the Center for Community Health (CCH) at the UNT Health Science Center in Fort Worth, Texas.

The HPV Vaccine Acceptability Study discovered a few major themes from its focus groups:

  • Most participants lacked information about the virus and the vaccine, but wanted a source of unbiased, trustworthy information.
  • Many participants were unwilling to have their children vaccinated for HPV due to negative perceptions of the vaccine. These perceptions were caused by distrust of the medical/ pharmaceutical community, as well as suspicions over the governor's mandate for the vaccine.
  • Many participants were concerned about the long-term side effects of the vaccine on their children.
  • Participants' decisions whether to vaccinate their children were complicated by the association between HPV and sexual activity. Many participants said they were teaching their child to abstain until marriage.

Furthermore, while the majority of women had learned about HPV and the HPV vaccine through TV commercials, they indicated that this was not a trusted source of information. Instead, women wanted to receive information from their children's schools or primary care physicians. Participants also indicated that they would like the information to be more readily available through other community avenues, like churches and libraries.

Participants were the mother or primary female caregiver of an African American girl between 7 and 18 years old. They had to be 24 years old or older, reside in Tarrant County, and speak English. When asked about their education levels, 32.6 percent had graduated high school or received their GED; 39.5 percent had one to three years of college; and 23.3 percent were college graduates.

Only 21 percent of participants indicated that they did not have a personal doctor or healthcare provider, and 84 percent reported they had visited their doctor in the previous year for a routine checkup. Despite these high levels of education and regular use of a primary healthcare provider, 51 percent answered false when asked if HPV is a sexually transmitted disease.

CCH and its study partners intend to use the information gathered from this study to create an awareness campaign to educate women about HPV and the HPV vaccine, so that they can make informed decisions about whether or not to have their daughters vaccinated.

The study was conducted in collaboration between Kathryn Cardarelli, PhD, director of the CCH, and Rachael Jackson, MPH, associate director of the CCH; Roberto Cardarelli, DO, MPH, director of the Primary Care Research Institute at the UNT Health Science Center; Anita Kurian, MBBS, DrPH, chief epidemiologist at Tarrant County Public Health; and Amy Raines, MPH, and Latawnya Peachy, MPH, with the City of Fort Worth Women's Health Initiative. The study was funded by ForHER, one of the UNT Health Science Center's Health Institutes of Texas. More information about this and other CCH projects can be found at www.centerforcommunityhealth.org.

University of North Texas Health Science Center

The University of North Texas Health Science Center is composed of the Texas College of Osteopathic Medicine, the Graduate School of Biomedical Sciences, the School of Public Health, and the School of Health Professions. The center's Institutes for Discovery conduct leading-edge research on select health issues, including vision, aging, cancer, heart disease, physical medicine and public health. This year, the Texas College of Osteopathic Medicine was named a top 50 medical school in primary care by U.S. News & World Report for the eighth consecutive year. The institution contributes almost $400 million to Tarrant County and Texas economies annually. For more information, visit www.hsc.unt.edu.


'/>"/>
SOURCE University of North Texas Health Science Center
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
2. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
3. Vaccine Stops Alzheimers Brain Tangles
4. Human Papilloma Virus vaccines may decrease chances of oral cancer
5. U.S. Teens Fall Short on Vaccine Coverage
6. Nasal Anthrax Vaccine Proves Effective in Animal Study
7. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
8. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
11. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... Youth Futures International (YFI) premiered its Serve, Learn, & Empower ... college students who have participated in the program every summer. The 2017 Serve, ... applications for enrollment. Visit http://www.ghana.yfiexperience.org to learn more. , “I have ...
(Date:3/29/2017)... Rouge, Louisiana (PRWEB) , ... March 29, 2017 ... ... HeartBoost in three Hours at a Walgreens store in Mississippi. AngioGenesis Labs, makers ... at Walgreens Stores in two southeastern states. Ingredients in HeartBoost, an over the ...
(Date:3/29/2017)... Mt. Horeb, WI (PRWEB) , ... March 29, 2017 , ... ... her patients on early orthodontic treatment and accepting new pediatric patients, with or without ... can help young patients have a better orthodontic outcome and experience. When patients receive ...
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a ... the finalization of the company’s executive management team with prominent executives from both inside ... Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who has more than twenty ...
(Date:3/29/2017)... Ca (PRWEB) , ... March 29, 2017 , ... Immunotherapy ... a growing number of cancers and is touted to be the next revolution in ... thus far, has been in the form of immune checkpoint inhibitors such as PD-1 ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... March 29, 2017  The leader in accelerated orthodontics, ... Sam Daher , Manal Ibrahim , ... Couchat will be the featured microlecture presenters at the ... Association of Orthodontists (AAO) Annual Session, April 21-25, 2017. ... microlectures beginning daily at 11:20 a.m. On the opening ...
(Date:3/29/2017)... , March 29, 2017  Glenmark Pharmaceuticals, a ... GSP 301, an investigational fixed-dose combination of mometasone ... administered twice-daily as a nasal spray being studied ... results are from a recently completed Phase 3 ... 301 combination therapy versus mometasone, olopatadine or placebo. ...
(Date:3/29/2017)... , March 29, 2017 ... a report, which provides an exhaustive study of ... study, nearly 242 companies are functional in this ... competitive. With the leading companies, such as GlaxoSmithKline ... LP, focusing aggressively on various marketing strategies to ...
Breaking Medicine Technology: